Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.13B | $524M | $144M | $144M | $436M | $471M | $495M | $527M | $568M | $604M |
| Revenue growth | — | -75.4% | -72.5% | 0.1% | 202.4% | 8.0% | 5.0% | 6.6% | 7.8% | 6.2% |
| Net income | $628M | $414M | $1.06B | $45.5M | $414M | $506M | $500M | $306M | $243M | $71.3M |
| Net margin | 29.5% | 79.0% | 735.8% | 31.5% | 94.7% | 107.3% | 101.1% | 58.0% | 42.8% | 11.8% |
| EPS (diluted) | $1.34 | $0.88 | $2.24 | $0.09 | $0.77 | $0.93 | $0.92 | $0.56 | $0.36 | $0.10 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.21B | $847M | $849M | $846M | $758M | $795M | $900M | $956M | $1.07B | $1.25B |
| Capital expenditures | $459M | $472M | $561M | $677M | $789M | $760M | $962M | $775M | $737M | $895M |
| Free cash flow | $755M | $375M | $288M | $169M | -$30.5M | $35.5M | -$61.7M | $182M | $334M | $357M |
| Share buybacks | $8.69M | $4.79M | $3.43M | $5.04M | $10.5M | $12.8M | $67.8M | $6.52M | $191M | $97.1M |
| Dividends paid | $980M | $695M | $697M | $720M | $787M | $650M | $648M | $657M | $795M | $849M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $94.7M | $55.3M | $54.0M | $80.4M | $44.2M | $158M | $72.0M | $118M | $120M | $467M |
| Total assets | $15.8B | $14.1B | $12.7B | $14.0B | $15.9B | $15.3B | $15.8B | $15.7B | $19.9B | $20.3B |
| Total liabilities | $9.82B | $8.49B | $6.21B | $7.37B | $8.57B | $8.11B | $8.48B | $8.77B | $10.9B | $12.0B |
| Long-term debt | $9.10B | $7.79B | $5.48B | $6.30B | $6.62B | $6.17B | $6.50B | $6.88B | $8.72B | $9.85B |
| Shareholders' equity | $5.55B | $5.30B | $5.94B | $6.09B | $6.73B | $6.52B | $6.65B | $6.35B | $8.40B | $7.50B |
| Shares (wtd avg diluted) | 467M | 469M | 475M | 489M | 531M | 539M | 539M | 547M | 676M | 696M |
Every figure is extracted from HEALTHPEAK PROPERTIES, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.